Drugs in Dev.
Oncology
Undisclosed
Finland 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Novo Seeds
Deal Size : $10.6 million
Deal Type : Series A Financing
Details : Rappta has developed proprietary tools and a unique understanding of PP2A which allows it to therapeutically reactivate PP2A.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 13, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Novo Seeds
Deal Size : $10.6 million
Deal Type : Series A Financing
